Physician profile
Ridwan I Alam
NPI 1356731772
$5,042.18
in general payments reported to CMS, 2019-2025
10 companies · $4,359 in 2025
The $4,359 reported for 2025 was more than what 90% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $683 · 2025: $4,359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,331 · Education: $1,500 · Travel and Lodging: $1,211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,331.43 |
| Education | $1,500.00 |
| Travel and Lodging | $1,210.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,520.86 | 2024-2025 | |
| Boston Scientific Corporation | $476.31 | 2024-2025 | Ams 700, Ams 800 Artificial Urinary Sphincter, Spaceoar Vue System - 10ml |
| Angiodynamics, INC. | $274.34 | 2024-2025 | Nanoknife |
| Progenics Pharmaceuticals, INC. | $210.47 | 2025 | |
| Kerecis Limited | $146.78 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Blue Earth Diagnostics | $134.22 | 2025 | Posluma |
| Astrazeneca Pharmaceuticals LP | $123.59 | 2025 | Lynparza |
| Telix Pharmaceuticals | $117.61 | 2025 | Illuccix |
| Tolmar, INC. | $21.20 | 2025 | Jatenzo |
| 180 Medical, INC. | $16.80 | 2024 | Gentlecath Glide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ridwan Alam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.